NIH-funded research R21 grant

Understanding how aging cells contribute to Alzheimer's disease

Official title: Dissecting the impact of senescence pathways on the cellular pathogenesis of Alzheimer's disease

Funded at Univ of Massachusetts Med Sch Worcester · NIH-10870871 · Data updated 2026-11-12

This study is looking at how aging brain cells might play a part in Alzheimer's disease and whether getting rid of these old cells can help improve brain function and lessen symptoms for people with the condition.

More s Disease research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester
NIH-funded
Lab location1 site (Worcester, United States)
Project startSeptember 30, 2024
Project endSeptember 29, 2026
Funding year2024
Award (this year)$460,625
NIH project number1R21AG086894-01
Project IDNIH-10870871 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with Alzheimer's disease or those at risk of developing it due to age or genetic factors.

Less likely to help

Patients with early-stage Alzheimer's or those with other forms of dementia unrelated to cellular senescence may not benefit from this research.

What this research studies

This research investigates the role of cellular senescence in the development of Alzheimer's disease (AD). It focuses on understanding how aging cells in the brain contribute to neurodegeneration and cognitive decline. By using human-derived stem cells, the researchers aim to explore specific senescence pathways that may drive the disease. The study will involve examining the effects of eliminating these senescent cells to see if it can improve brain function and reduce AD symptoms.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that slow down or prevent the progression of Alzheimer's disease.

How similar studies have gone: Previous research has shown promising results in targeting senescent cells to improve cognitive function in animal models of Alzheimer's disease, indicating potential for success in this approach.

Where this research is happening

  • Univ of Massachusetts Med Sch Worcester
    Worcester, United States
    Active

Researchers

  • Principal investigator: Zhang, Hong — Univ of Massachusetts Med Sch Worcester
  • Study coordinator: Zhang, Hong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.